Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8681 |
High Similarity |
NPD4380 |
Phase 2 |
0.8613 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8613 |
High Similarity |
NPD1510 |
Phase 2 |
0.8593 |
High Similarity |
NPD943 |
Approved |
0.8593 |
High Similarity |
NPD1240 |
Approved |
0.8592 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8429 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8392 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8378 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8357 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8357 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8212 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8207 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8092 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8074 |
Intermediate Similarity |
NPD1164 |
Approved |
0.8067 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7958 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD1470 |
Approved |
0.791 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7902 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7902 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7902 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7902 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7891 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.782 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7792 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2801 |
Approved |
0.777 |
Intermediate Similarity |
NPD1511 |
Approved |
0.774 |
Intermediate Similarity |
NPD2800 |
Approved |
0.774 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD920 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7535 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7519 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7519 |
Intermediate Similarity |
NPD74 |
Approved |
0.75 |
Intermediate Similarity |
NPD5403 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7467 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD940 |
Approved |
0.746 |
Intermediate Similarity |
NPD846 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD3400 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7442 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7442 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7344 |
Intermediate Similarity |
NPD1237 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7225 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7179 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6190 |
Approved |
0.716 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7143 |
Intermediate Similarity |
NPD919 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7103 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7031 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD5048 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD520 |
Approved |
0.7 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7 |
Intermediate Similarity |
NPD3019 |
Approved |
0.6993 |
Remote Similarity |
NPD7003 |
Approved |
0.6989 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD2934 |
Approved |
0.6984 |
Remote Similarity |
NPD2933 |
Approved |
0.6981 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6962 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6099 |
Approved |
0.6954 |
Remote Similarity |
NPD6100 |
Approved |
0.6939 |
Remote Similarity |
NPD3268 |
Approved |
0.6932 |
Remote Similarity |
NPD6535 |
Approved |
0.6932 |
Remote Similarity |
NPD6534 |
Approved |
0.6913 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD6407 |
Approved |
0.6892 |
Remote Similarity |
NPD6405 |
Approved |
0.6887 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6885 |
Remote Similarity |
NPD7584 |
Approved |
0.6883 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1876 |
Approved |
0.687 |
Remote Similarity |
NPD1930 |
Approved |
0.687 |
Remote Similarity |
NPD1929 |
Approved |
0.687 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6857 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6846 |
Remote Similarity |
NPD1613 |
Approved |
0.6846 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6777 |
Approved |
0.6833 |
Remote Similarity |
NPD6781 |
Approved |
0.6833 |
Remote Similarity |
NPD6778 |
Approved |
0.6833 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6782 |
Approved |
0.6833 |
Remote Similarity |
NPD6776 |
Approved |
0.6833 |
Remote Similarity |
NPD6780 |
Approved |
0.6833 |
Remote Similarity |
NPD6779 |
Approved |
0.6832 |
Remote Similarity |
NPD37 |
Approved |
0.6832 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6828 |
Remote Similarity |
NPD2797 |
Approved |
0.6816 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD4662 |
Approved |
0.6815 |
Remote Similarity |
NPD4661 |
Approved |
0.6812 |
Remote Similarity |
NPD5951 |
Approved |
0.6802 |
Remote Similarity |
NPD8312 |
Approved |
0.6802 |
Remote Similarity |
NPD8313 |
Approved |
0.68 |
Remote Similarity |
NPD447 |
Suspended |
0.68
|
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |